Early Research Suggests a Path to Predict and Prevent Lung Cancer
The New York Times • • health
Key Points:
- Scientists have identified a set of blood proteins that can predict lung cancer risk more than five years before diagnosis, potentially enabling earlier intervention.
- Early evidence suggests an existing anti-inflammatory drug may significantly reduce lung cancer risk in individuals with elevated levels of these proteins linked to inflammation.
- Further research and randomized trials are needed to develop a clinical test and confirm the drug’s preventive effectiveness.
- The findings, published in the journal Cell, represent a promising advance toward lung cancer prevention, a goal that has long eluded researchers.
- Despite progress in screening and treatment, lung cancer remains the most diagnosed cancer worldwide with low five-year survival rates, highlighting the importance of prevention efforts.